Follow
Behar-Cohen
Behar-Cohen
Chercheur,
Verified email at crc.jussieu.fr
Title
Cited by
Cited by
Year
Ferric carboxymaltose in patients with heart failure and iron deficiency
SD Anker, J Comin Colet, G Filippatos, R Willenheimer, K Dickstein, ...
New England Journal of Medicine 361 (25), 2436-2448, 2009
24512009
Central serous chorioretinopathy: recent findings and new physiopathology hypothesis
A Daruich, A Matet, A Dirani, E Bousquet, M Zhao, N Farman, F Jaisser, ...
Progress in retinal and eye research 48, 82-118, 2015
9332015
CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration
C Combadière, C Feumi, W Raoul, N Keller, M Rodéro, A Pézard, ...
The Journal of clinical investigation 117 (10), 2920-2928, 2007
6282007
Mechanisms of macular edema: beyond the surface
A Daruich, A Matet, A Moulin, L Kowalczuk, M Nicolas, A Sellam, ...
Progress in retinal and eye research 63, 20-68, 2018
5692018
Light-emitting diodes (LED) for domestic lighting: any risks for the eye?
F Behar-Cohen, C Martinsons, F Viénot, G Zissis, A Barlier-Salsi, ...
Progress in retinal and eye research 30 (4), 239-257, 2011
5322011
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles
JL Bourges, SE Gautier, F Delie, RA Bejjani, JC Jeanny, R Gurny, ...
Investigative ophthalmology & visual science 44 (8), 3562-3569, 2003
4812003
Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
M Zhao, I Célérier, E Bousquet, JC Jeanny, L Jonet, M Savoldelli, O Offret, ...
The Journal of clinical investigation 122 (7), 2672-2679, 2012
4082012
Cyclosporine A delivery to the eye: a pharmaceutical challenge
F Lallemand, O Felt-Baeyens, K Besseghir, F Behar-Cohen, R Gurny
European Journal of Pharmaceutics and Biopharmaceutics 56 (3), 307-318, 2003
3322003
Ranibizumab versus bevacizumab for neovascular age-related macular degeneration: results from the GEFAL noninferiority randomized trial
L Kodjikian, EH Souied, G Mimoun, M Mauget-Faÿsse, F Behar-Cohen, ...
Ophthalmology 120 (11), 2300-2309, 2013
3302013
Intraocular implants for extended drug delivery: therapeutic applications
JL Bourges, C Bloquel, A Thomas, F Froussart, A Bochot, F Azan, R Gurny, ...
Advanced drug delivery reviews 58 (11), 1182-1202, 2006
3182006
CCR 2+ monocytes infiltrate atrophic lesions in age‐related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice
F Sennlaub, C Auvynet, B Calippe, S Lavalette, L Poupel, SJ Hu, ...
EMBO molecular medicine 5 (11), 1775-1793, 2013
2792013
Retinal damage induced by commercial light emitting diodes (LEDs)
I Jaadane, P Boulenguez, S Chahory, S Carré, M Savoldelli, L Jonet, ...
Free Radical Biology and Medicine 84, 373-384, 2015
2632015
Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study
E Bousquet, T Beydoun, M Zhao, L Hassan, O Offret, F Behar-Cohen
Retina 33 (10), 2096-2102, 2013
2462013
Nanoparticles for gene delivery to retinal pigment epithelial cells
RA Bejjani, D BenEzra, H Cohen, J Rieger, C Andrieu, JC Jeanny, ...
Mol Vis 11 (2), 124-32, 2005
2412005
The outer limiting membrane (OLM) revisited: clinical implications
S Omri, B Omri, M Savoldelli, L Jonet, B Thillaye-Goldenberg, G Thuret, ...
Clinical ophthalmology, 183-195, 2010
2262010
Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model
S Omri, F Behar-Cohen, Y De Kozak, F Sennlaub, LM Verissimo, L Jonet, ...
The American journal of pathology 179 (2), 942-953, 2011
2112011
Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy
F Sennlaub, F Valamanesh, A Vazquez-Tello, AM El-Asrar, D Checchin, ...
Circulation 108 (2), 198-204, 2003
2032003
Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders
RF Spaide, CMG Cheung, H Matsumoto, S Kishi, CJF Boon, EHC van Dijk, ...
Progress in retinal and eye research 86, 100973, 2022
1982022
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo …
A Lotery, S Sivaprasad, A O'Connell, RA Harris, L Culliford, L Ellis, A Cree, ...
The Lancet 395 (10220), 294-303, 2020
1792020
Ultraviolet damage to the eye revisited: eye-sun protection factor (E-SPF®), a new ultraviolet protection label for eyewear
F Behar-Cohen, G Baillet, T de Ayguavives, PO Garcia, J Krutmann, ...
Clinical Ophthalmology, 87-104, 2013
1772013
The system can't perform the operation now. Try again later.
Articles 1–20